DelNova: Addressing complications from Botox (217)

Episode 17 May 24, 2022 00:19:03
DelNova: Addressing complications from Botox (217)
Innovation4Alpha
DelNova: Addressing complications from Botox (217)

May 24 2022 | 00:19:03

/

Show Notes

DelNova, Inc. is a biopharmaceutical company focused on addressing unmet medical needs. DelNova is resolving complications arising from botulinum toxin therapies (eg. Botox®). The first product under development, ReViVox™ is based on a clinically validated drug currently approved for a different medical use and route of administration. The novel formulation will manage undesirable side effects resulting from neurotoxin injections in both medical and cosmetic applications. 

Other Episodes

Episode 12

July 21, 2021 00:44:33
Episode Cover

Clinician Innovator and Investor: Jeremy Krell, DMD (012)

Dr. Krell is a fascinating general dentist with a combined business background. He is currently the Head of Marketing at Simplifeye, based in NYC,...

Listen

Episode 27

November 26, 2021 00:27:25
Episode Cover

Matan Magril - Innovator, Investor and Guide (027)

One of the most creative, insightful and articulate startup leaders in the industry, Matan Magril is always fascinating to talk with. At 22, he...

Listen

Episode 7

March 01, 2022 00:31:53
Episode Cover

Saralyn Mark, MD - Human centered design on Earth and in Space (207)

Saralyn Mark, MD, a world renowned leader in women’s health, is an endocrinologist, geriatrician and women’s health specialist. She was the first Senior Medical...

Listen